Literature DB >> 2001579

Alternative therapies, 1990. An overview.

L S McGinnis1.   

Abstract

The availability of alternative therapies for many health problems is a well-documented historical fact. Alternative therapies are generally understood to be those therapies outside of the usually accepted medical therapies for disease processes, such as cancer, arthritis, diabetes, psoriasis, lupus, and AIDS. Some other descriptive terms utilized include questionable, unproven, dubious, unorthodox, and unconventional. These alternative therapies vary from active involvement in promotion of one's own health (exercise, diet) to quackery. In today's society, with emphasis on self-involvement with individual health, metabolic therapies have become the most widely practiced alternative therapy. In an antiestablishment, anti-intellectual climate, with an increasingly mobile, rootless population, alternative therapies are in somewhat of a renaissance. Some confusion exists regarding clinical trials and alternative therapies in the general population and in the noninvolved health profession. Various studies indicate that from 10% to 50% of cancer patients use some alternative therapy, with national expenditures ranging as high as $10 billion annually. Better-educated patients with higher-than-average income are more likely to choose alternative therapies and are frequently supported by a physician in this choice. Most cancer patients continue under a physician's care and continue usual therapy while pursuing alternative methods. Approximately 5% of cancer patients abandon appropriate therapy and pursue potentially harmful alternative methods. A variety of sociomedical questions are brought forth by studies of the use of alternative therapies. A great need for public and professional education regarding this subject is evident.

Entities:  

Mesh:

Year:  1991        PMID: 2001579     DOI: 10.1002/cncr.2820671817

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Complementary medicine: state of the evidence.

Authors:  C Vincent; A Furnham
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

2.  Unconventional cancer therapy--survey of patients with gynaecological malignancy.

Authors:  K Münstedt; K Kirsch; W Milch; S Sachsse; H Vahrson
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

Review 3.  Polypharmacy. Pharmacokinetic perspectives.

Authors:  P K Honig; L R Cantilena
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

4.  Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD).

Authors:  Craig W Hayden; Charles N Bernstein; Renée A Hall; Nimish Vakil; Harinder S Garewal; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

Review 5.  Unproven (questionable) cancer therapies.

Authors:  M L Brigden
Journal:  West J Med       Date:  1995-11

6.  The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study.

Authors:  Huiyan Ma; Catherine L Carpenter; Jane Sullivan-Halley; Leslie Bernstein
Journal:  BMC Cancer       Date:  2011-06-06       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.